CENIT AG (CSH.DE) Stock Fundamental Analysis

FRA:CSH • DE0005407100

6.44 EUR
0 (0%)
Last: Feb 25, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Taking everything into account, CSH scores 3 out of 10 in our fundamental rating. CSH was compared to 112 industry peers in the Software industry. Both the profitability and financial health of CSH have multiple concerns. CSH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year CSH has reported negative net income.
  • CSH had a positive operating cash flow in the past year.
  • Of the past 5 years CSH 4 years were profitable.
  • CSH had a positive operating cash flow in each of the past 5 years.
CSH.DE Yearly Net Income VS EBIT VS OCF VS FCFCSH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -3.14%, CSH is doing worse than 65.18% of the companies in the same industry.
  • CSH has a Return On Equity of -12.50%. This is in the lower half of the industry: CSH underperforms 69.64% of its industry peers.
  • CSH has a Return On Invested Capital (1.04%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CSH is significantly below the industry average of 12.70%.
Industry RankSector Rank
ROA -3.14%
ROE -12.5%
ROIC 1.04%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
CSH.DE Yearly ROA, ROE, ROICCSH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

  • CSH has a Operating Margin of 0.91%. This is comparable to the rest of the industry: CSH outperforms 45.54% of its industry peers.
  • In the last couple of years the Operating Margin of CSH has declined.
  • Looking at the Gross Margin, with a value of 60.04%, CSH is doing worse than 64.29% of the companies in the same industry.
  • CSH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.91%
PM (TTM) N/A
GM 60.04%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
CSH.DE Yearly Profit, Operating, Gross MarginsCSH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CSH is destroying value.
  • Compared to 1 year ago, CSH has about the same amount of shares outstanding.
  • CSH has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CSH has a worse debt to assets ratio.
CSH.DE Yearly Shares OutstandingCSH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CSH.DE Yearly Total Debt VS Total AssetsCSH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 2.13 indicates that CSH is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CSH has a Altman-Z score (2.13) which is in line with its industry peers.
  • CSH has a debt to FCF ratio of 4.02. This is a neutral value as CSH would need 4.02 years to pay back of all of its debts.
  • CSH has a Debt to FCF ratio of 4.02. This is comparable to the rest of the industry: CSH outperforms 51.79% of its industry peers.
  • A Debt/Equity ratio of 1.10 is on the high side and indicates that CSH has dependencies on debt financing.
  • CSH's Debt to Equity ratio of 1.10 is on the low side compared to the rest of the industry. CSH is outperformed by 83.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.02
Altman-Z 2.13
ROIC/WACC0.16
WACC6.54%
CSH.DE Yearly LT Debt VS Equity VS FCFCSH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 1.27 indicates that CSH should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.27, CSH is in line with its industry, outperforming 41.96% of the companies in the same industry.
  • A Quick Ratio of 1.27 indicates that CSH should not have too much problems paying its short term obligations.
  • CSH has a Quick ratio (1.27) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
CSH.DE Yearly Current Assets VS Current LiabilitesCSH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • CSH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -252.87%.
  • Looking at the last year, CSH shows a small growth in Revenue. The Revenue has grown by 3.58% in the last year.
  • Measured over the past years, CSH shows a small growth in Revenue. The Revenue has been growing by 3.84% on average per year.
EPS 1Y (TTM)-252.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.27%
Revenue 1Y (TTM)3.58%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%-3.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.23% on average over the next years. This is quite good.
  • Based on estimates for the next years, CSH will show a small growth in Revenue. The Revenue will grow by 2.56% on average per year.
EPS Next Y-228.95%
EPS Next 2Y-39.3%
EPS Next 3Y16.23%
EPS Next 5YN/A
Revenue Next Year-6.06%
Revenue Next 2Y2.96%
Revenue Next 3Y3.64%
Revenue Next 5Y2.56%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CSH.DE Yearly Revenue VS EstimatesCSH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M 200M
CSH.DE Yearly EPS VS EstimatesCSH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CSH. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 45.54, which means the current valuation is very expensive for CSH.
  • CSH's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.03, CSH is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 45.54
CSH.DE Price Earnings VS Forward Price EarningsCSH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CSH is valued cheaply inside the industry as 88.39% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CSH indicates a rather cheap valuation: CSH is cheaper than 97.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.73
EV/EBITDA 6.34
CSH.DE Per share dataCSH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CSH's earnings are expected to grow with 16.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-39.3%
EPS Next 3Y16.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.15%, CSH is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.73, CSH pays a better dividend. On top of this CSH pays more dividend than 95.54% of the companies listed in the same industry.
  • CSH's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 4.15%

5.2 History

  • The dividend of CSH decreases each year by -41.82%.
Dividend Growth(5Y)-41.82%
Div Incr Years0
Div Non Decr Years0
CSH.DE Yearly Dividends per shareCSH.DE Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

DP0%
EPS Next 2Y-39.3%
EPS Next 3Y16.23%
CSH.DE Yearly Income VS Free CF VS DividendCSH.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

More info and screens

Find the best dividend stocksShow peers with best dividend

CENIT AG

FRA:CSH (2/25/2026, 7:00:00 PM)

6.44

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-06
Earnings (Next)04-09
Inst Owners47.47%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap53.90M
Revenue(TTM)210.10M
Net Income(TTM)-4.64M
Analysts90
Price Target13.52 (109.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.15%
Yearly Dividend0.04
Dividend Growth(5Y)-41.82%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 45.54
P/S 0.26
P/FCF 4.73
P/OCF 4.14
P/B 1.45
P/tB N/A
EV/EBITDA 6.34
EPS(TTM)-0.55
EYN/A
EPS(NY)0.14
Fwd EY2.2%
FCF(TTM)1.36
FCFY21.14%
OCF(TTM)1.56
OCFY24.15%
SpS25.1
BVpS4.43
TBVpS-2.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.14%
ROE -12.5%
ROCE 2.14%
ROIC 1.04%
ROICexc 1.35%
ROICexgc 9.09%
OM 0.91%
PM (TTM) N/A
GM 60.04%
FCFM 5.42%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
ROICexc(3y)4.78%
ROICexc(5y)6.49%
ROICexgc(3y)14.59%
ROICexgc(5y)14.62%
ROCE(3y)8.58%
ROCE(5y)8.95%
ROICexgc growth 3Y-6.55%
ROICexgc growth 5Y-5.33%
ROICexc growth 3Y-30.45%
ROICexc growth 5Y-21.57%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
F-Score5
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.02
Debt/EBITDA 3.27
Cap/Depr 15.31%
Cap/Sales 0.77%
Interest Coverage 0.57
Cash Conversion 104.1%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 2.13
F-Score5
WACC6.54%
ROIC/WACC0.16
Cap/Depr(3y)19.26%
Cap/Depr(5y)16.81%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-252.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.27%
EPS Next Y-228.95%
EPS Next 2Y-39.3%
EPS Next 3Y16.23%
EPS Next 5YN/A
Revenue 1Y (TTM)3.58%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%-3.04%
Revenue Next Year-6.06%
Revenue Next 2Y2.96%
Revenue Next 3Y3.64%
Revenue Next 5Y2.56%
EBIT growth 1Y-77.74%
EBIT growth 3Y3.24%
EBIT growth 5Y-5.88%
EBIT Next Year29.61%
EBIT Next 3Y44.31%
EBIT Next 5Y27.42%
FCF growth 1Y70.64%
FCF growth 3Y5.1%
FCF growth 5Y-0.8%
OCF growth 1Y50.13%
OCF growth 3Y7.86%
OCF growth 5Y-2.42%

CENIT AG / CSH.DE FAQ

What is the fundamental rating for CSH stock?

ChartMill assigns a fundamental rating of 3 / 10 to CSH.DE.


What is the valuation status of CENIT AG (CSH.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to CENIT AG (CSH.DE). This can be considered as Overvalued.


How profitable is CENIT AG (CSH.DE) stock?

CENIT AG (CSH.DE) has a profitability rating of 3 / 10.


What is the earnings growth outlook for CENIT AG?

The Earnings per Share (EPS) of CENIT AG (CSH.DE) is expected to decline by -228.95% in the next year.


Is the dividend of CENIT AG sustainable?

The dividend rating of CENIT AG (CSH.DE) is 6 / 10 and the dividend payout ratio is 0%.